The epidemic of new coronavirus pneumonia that broke out in Wuhan in December 2019 is beyond doubt a disaster especially for cancer patients. There are limited data on the clinical characteristics of cancer patients with SARS-CoV-2 infection, and treatments based on this aspect are rarely mentioned. According to relevant medical literature and websites, this article aims to summarize the immune status, chemotherapy, radiotherapy and endocrine therapy for cancer patients in the state of new coronavirus pneumonia infection, hoping to provide a reference for clinical practice.
COVID-19; Cancer; Treatment; Administration